Jeff Jochims Appointed Executive Chair at Genesee Scientific

Seasoned Life Sciences Executive to Guide Accelerated Growth

Genesee Scientific, a leading provider of laboratory essentials for the life sciences industry, is pleased to announce the elevation of Jeff Jochims’ role to Executive Chair of the Board. Jochims has served as a member of Genesee’s Board of Directors since 2023 and has over 25 years of executive leadership experience in healthcare and life sciences distribution.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250528156717/en/

Jeff Jochims Appointed Executive Chair at Genesee Scientific

“Jeff’s deep industry expertise and strategic vision make him an exceptional fit for Genesee Scientific at this critical stage of our growth,” said Dan Monahan, CEO. “His track record in scaling operational excellence and commercial strategy in life sciences distribution will be invaluable as we expand our impact across research and diagnostic markets.”

Jochims has held prominent executive leadership roles at Thermo Fisher Scientific and Owens & Minor and currently serves as Chief Executive Officer at I2Pure. His appointment signals Genesee Scientific’s continued investment in delivering high-quality, cost-effective solutions to research and diagnostic labs. “I’m excited to help shape the future of Genesee Scientific,” said Jochims. “The company has a strong foundation, a clear value proposition, and a passionate team committed to supporting scientists. I look forward to contributing to its next chapter.”

About Genesee Scientific

For over 30 years, Genesee Scientific has been dedicated to supporting scientific discovery by supplying reliable, high-quality laboratory products at exceptional value. Serving academic institutions, diagnostic labs, and biotech companies, Genesee empowers researchers to focus on advancing science.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250528156717/en/